Latamoxef-induced coagulation disorders: Incidence and risk factors.

Cai, Yan; Zhang, Minggang; Wang, Yan; Wang, Na; Zhang, Li; Zhang, Kanghuai

Cai, Yan; Zhang, Minggang; Wang, Yan; Wang, Na; Zhang, Li; Zhang, Kanghuai.

Affiliation

Cai Y; Department of Pharmacy, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zhang M; Department of Blood Transfusion, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Wang Y; Department of Pharmacy, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Wang N; Department of Pharmacy, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zhang L; Department of Pharmacy, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zhang K; Department of Pharmacy, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

J Clin Pharm Ther ; 46(5): 1382-1386, 2021 Oct.

Article de En | MEDLINE | ID: mdl-34114239

Sujet(s)
Mots clés

bleeding; coagulation disorders; latamoxef

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Troubles de l'hémostase et de la coagulation / Antibactériens / Latamoxef Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Clin Pharm Ther Sujet du journal: FARMACIA / TERAPEUTICA Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google